Question 1

What is the catalog number for CPI17 alpha, phosphorylated (Thr38)?

Accepted Answer

The catalog number for CPI17 alpha, phosphorylated (Thr38) is 399432.

Question 2

What sizes are available for CPI17 alpha, phosphorylated (Thr38)?

Accepted Answer

CPI17 alpha, phosphorylated (Thr38) is available in the following size(s): 50 µL, 100 µL.

Question 3

How many pack sizes does CPI17 alpha, phosphorylated (Thr38) come in?

Accepted Answer

CPI17 alpha, phosphorylated (Thr38) is available in 2 different pack sizes.

Question 4

Is CPI17 alpha, phosphorylated (Thr38) in stock?

Accepted Answer

CPI17 alpha, phosphorylated (Thr38) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Question 6

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Question 7

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

CPI17 alpha, phosphorylated (Thr38)

Product Specifications

Clonality

Available Sizes

Frequently Asked Questions

Explore Other Products

Gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker) (PMEL/1825R), CF568 conjugate, 0.1mg/mL

CDC25A Polyclonal Antibody

CDC25A Polyclonal Antibody

CDC25A Polyclonal Antibody

CD66 (CEA) (COL-1 + CEA31 + C66/261), Biotin conjugate, 0.1mg/mL

AF/LE Purified Anti-Human HLA-DR Antibody[L243]